Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors — drugs that take the brakes off ...

Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

I am excited to update you on our overall strategy, progress, and key priorities and goals for 2025. Strategic Overview and ...

Healers have treated their patients with silk throughout history. Now they're harnessing its strength, biocompatibility, and ...

Funding cuts, firings and program closures at the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH) and U.S. Agency for ...

As the dark clouds gather and the first drops of rain hit the earth, there is a sense of relief from the heat. But along with ...